Mesoblast (MEOBF) Cash from Investing Activities (2014 - 2023)
Mesoblast's (MEOBF) quarterly Cash from Investing Activities came in at $16000.0 in Q2 2023, up 134.04% year-over-year from $6836.4 in Q2 2022, and down 40.74% quarter-over-quarter from $27000.0 in Q1 2023.
Analysis
Mesoblast (MEOBF) Cash from Investing Activities (2014 - 2023) Analysis & Trends
Mesoblast has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $16000.0 for Q2 2023.
- In Q2 2023, Cash from Investing Activities rose 134.04% year-over-year to $16000.0; the TTM figure through Jun 2023 stood at -$194000.0 (up 16.38% YoY), while the FY2026 annual figure was -$1.0 million, down 952.5% from the prior year.
- Cash from Investing Activities came in at $16000.0 for Q2 2023 at Mesoblast, down from $27000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q1 2023 to a low of -$1.4 million in Q1 2020.
- Average Cash from Investing Activities over 5 years is -$283312.5, with a median of -$94500.0 recorded in 2019.
- Year-over-year, Cash from Investing Activities tumbled 1461.11% in 2020 and jumped 148.21% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$712000.0 in 2019, then soared by 42.84% to -$407000.0 in 2020, then jumped by 92.63% to -$30000.0 in 2021, then slipped by 13.33% to -$34000.0 in 2022, then surged by 147.06% to $16000.0 in 2023.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $16000.0 in Q2 2023, $27000.0 in Q1 2023, and -$34000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -161.58 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -55.66 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -74.05 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -120.00 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 53.26 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -9.88 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 26.69 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -93.37 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | -2.82 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -30,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Jun 30, 2021 | -223,000.00 |
| Mar 31, 2021 | -936,000.00 |
| Dec 31, 2020 | -407,000.00 |
| Sep 30, 2020 | -81,000.00 |
| Mar 31, 2020 | -1.41 Mn |
| Dec 31, 2019 | -712,000.00 |
| Sep 30, 2019 | -253,000.00 |
| Mar 31, 2019 | -90,000.00 |
| Dec 31, 2018 | 141,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -436,000.00 |
| Mar 31, 2018 | -37,000.00 |